Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-29

Clinical Trial Update: Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine [Phase 3]

View source ↗

Summary

A completed Phase 3 trial comparing entecavir to lamivudine for antiviral prophylaxis in patients undergoing chemotherapy. The study includes patients with canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENTECAVIR (ENTECAVIR)
  • Lamivudine (lamivudine)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Malignancy, Hepatitis B | Phase 3 | Status: COMPLETED